Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Center for Emerging Technologies (CET) is a premier bioscience and technology incubator located in the heart of the Cortex Innovation Community in St. Louis, Missouri. Founded in 1998, CET provides early-stage companies with specialized infrastructure, including wet laboratory space, shared scientific equipment, and office facilities. The center offers a comprehensive suite of entrepreneurial support services, such as business development assistance, mentoring, and access to capital networks. CET focuses on fostering startups in the life sciences, medical technology, and information technology sectors to accelerate their path to commercialization. As a non-profit affiliate of Cortex, it plays a vital role in the regional innovation ecosystem by bridging the gap between academic research and the marketplace. Over its history, CET has supported numerous successful startups that have contributed significantly to the St. Louis economy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on St. Louis Center for Emerging Technologies.